This Week in BMC Cancer

Premium

In BMC Cancer this week, researchers in Taiwan say that both isoforms of the Tazarotene-induced gene 1 tumor supressor gene supress cell growth in human colon cancer cell lines. Although the B isoform of TIG1 is known to inhibit growth and invasion of cancer cells, not much is known about the A isoform, the researchers write. In this study, the team found that both TGI1 isoforms are expressed at high levels in normal prostate tissue, and are downregulated in colon cancer cell lines.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.